DRUG DEVELOPMENT SOLUTIONS LIMITED
DRUG DEVELOPMENT SOLUTIONS LIMITED is a Private limited company (Ltd.) registered in United Kingdom under 13985205, and its current status with Companies House is active. The company was incorporated on 17 March 2022 and lists its registered address as ELY, United Kingdom. 1 shareholder is on record for DRUG DEVELOPMENT SOLUTIONS LIMITED, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Companies House and was last updated on 9 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
1
One shareholder is currently on record for DRUG DEVELOPMENT SOLUTIONS LIMITED, held on the Confirmation Statement (CS01), filed under the Companies Act 2006.
The largest of these is ALLIANCE BUYER INC., holding 100% — a majority holding.
Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| ALLIANCE BUYER INC. | 100% | Companies House |
Officers
5
Two of the 5 officer records shown for DRUG DEVELOPMENT SOLUTIONS LIMITED are current appointments, filed with Companies House. Alexander Abramov (appointed 2023-04-01) and Robert Stachlewitz Iii (appointed 2024-12-11) both serve as Director. The remaining 3 records shown (Patrick Bennett, Michael Van Der Merwe and 1 other) are former appointments that have since been resigned.
The register reports 8 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at DRUG DEVELOPMENT SOLUTIONS LIMITED sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns DRUG DEVELOPMENT SOLUTIONS LIMITED?
One shareholder is currently on record for DRUG DEVELOPMENT SOLUTIONS LIMITED, held on the Confirmation Statement (CS01), filed under the Companies Act 2006. The largest of these is ALLIANCE BUYER INC., holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is DRUG DEVELOPMENT SOLUTIONS LIMITED's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for DRUG DEVELOPMENT SOLUTIONS LIMITED is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does DRUG DEVELOPMENT SOLUTIONS LIMITED have on record?
1 shareholder is shown on record for DRUG DEVELOPMENT SOLUTIONS LIMITED.
What is DRUG DEVELOPMENT SOLUTIONS LIMITED's company registration number?
DRUG DEVELOPMENT SOLUTIONS LIMITED's registration number is 13985205, filed with Companies House in United Kingdom. Its current status on the register is active.
Is DRUG DEVELOPMENT SOLUTIONS LIMITED still an active company?
DRUG DEVELOPMENT SOLUTIONS LIMITED's status on Companies House is listed as active.
When was DRUG DEVELOPMENT SOLUTIONS LIMITED incorporated?
DRUG DEVELOPMENT SOLUTIONS LIMITED was incorporated on 17 March 2022, according to Companies House.
What is DRUG DEVELOPMENT SOLUTIONS LIMITED's registered address?
The registered address on file for DRUG DEVELOPMENT SOLUTIONS LIMITED is ELY, United Kingdom.
What legal structure is DRUG DEVELOPMENT SOLUTIONS LIMITED registered as?
DRUG DEVELOPMENT SOLUTIONS LIMITED is registered as a Private limited company (Ltd.) in United Kingdom.
Who are the officers/directors of DRUG DEVELOPMENT SOLUTIONS LIMITED?
Two of the 5 officer records shown for DRUG DEVELOPMENT SOLUTIONS LIMITED are current appointments, filed with Companies House. Alexander Abramov (appointed 2023-04-01) and Robert Stachlewitz Iii (appointed 2024-12-11) both serve as Director. The remaining 3 records shown (Patrick Bennett, Michael Van Der Merwe and 1 other) are former appointments that have since been resigned. Management authority at DRUG DEVELOPMENT SOLUTIONS LIMITED sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to DRUG DEVELOPMENT SOLUTIONS LIMITED's ownership over time?
This profile reflects a point-in-time snapshot from Companies House. Zavia's monitoring API can track changes to DRUG DEVELOPMENT SOLUTIONS LIMITED's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access DRUG DEVELOPMENT SOLUTIONS LIMITED's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United Kingdom, so records like DRUG DEVELOPMENT SOLUTIONS LIMITED's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Companies House and was last synced on 9 October 2026.